This is the authors' abstract. We don't add key points for this paper.
INTRODUCTION A higher incidence of dementia, including Alzheimer's‐like pathology, is observed in aged people living with human immunodeficiency virus‐1 (HIV‐1). However, mechanisms linking HIV‐1 to Alzheimer's disease (AD) pathology remain unclear, due to the lack of animal models that allow for concurrent studies of HIV‐1 and AD. METHODS We created a novel amyloid precursor protein (APP) (Swedish mutation) knock‐in (KI) AD mouse on an immunocompromised NOG background, NOG/APP KM670,671NL /IL‐34 (NAIL). Following CD34+ hematopoietic stem cell (HSC) reconstitution, humanized hNAIL mice develop human microglia‐like cells in the brain and human immune system in the periphery. This allows, for the first time, studies of progressive brain HIV‐1 replication in an AD brain. Four‐month‐old HSC reconstituted mice were infected with the HIV‐1 ADA strain, and evaluated at 8 weeks post infection to study the role of brain HIV‐1 replication on AD‐like pathologies. RESULTS HIV‐1 replication increased amyloid‐beta (Aβ) load in the brain and reduced synaptic and neuronal integrity. Cell type‐specific spatial transcriptomic analysis demonstrated that Aβ and HIV‐1 drive distinct transcriptional patterns, whereas dual pathology amplified AD‐like pathology. Neurons showed the highest transcriptional change, with genes linked to neuroinflammation, protein trafficking, and synaptic dysfunction. DISCUSSION The hNAIL mice enable interrogation of HIV–AD comorbidities, with a future potential for the development of novel therapeutic interventions.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bhattarai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: